Don't get left behind! The modernized is coming. Check it out now.
Say goodbye to!
The new site is coming soon - go to the modernized
Working… Menu

Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02764541
Recruitment Status : Active, not recruiting
First Posted : May 6, 2016
Last Update Posted : July 18, 2022
Information provided by (Responsible Party):
Otto Metzger, Dana-Farber Cancer Institute

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : February 2022
Estimated Study Completion Date : April 2031
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 February 15, 2023
March 14, 2023
2 April 18, 2023
May 10, 2023